Currently, out of the existing stock ratings of Glen Santangelo - 50 which are a Hold (38.76%), 76 which are a Buy (58.91%), 3 which are a Sell (2.33%)

Glen Santangelo

Work Performance Price Targets & Ratings Chart

Analyst Glen Santangelo works at JEFFERIES and is covering Healthcare, Consumer Defensive, Technology sectors with 266 price targets and ratings displayed on 33 stocks. Previously, Glen Santangelo worked at GUGGENHEIM, DEUTSCHE BANK, CREDIT SUISSE.

Glen Santangelo's average stock forecast success ratio is 64.7% with an average time for price targets to be met of 177.67 days.

Most recent stock forecast was given on ACCD, Accolade at 09-Feb-2023.

Wall Street Analyst Glen Santangelo

Analyst best performing recommendations are on TRHC (TABULA RASA HEALTHCARE).
The best stock recommendation documented was for TRHC (TABULA RASA HEALTHCARE) at 12/3/2021. The price target of $13 was fulfilled within 11 days with a profit of $2.65 (25.6%) receiving and performance score of 23.28.

Average potential price target upside

of $25.99 (18.76%) on MCK (MCKESSON).
of $19.63 (14.67%) on ALGN (ALIGN TECHNOLOGY).
of $19.38 (30.48%) on ABC (AMERISOURCEBERGEN).

ABC AmerisourceBergen BBLN CAH Cardinal Health DOCS DPLO HCAT Health Catalyst HMSY HQY HealthEquity HSIC Henry Schein MCK McKesson MDSO PDCO Patterson Companies PGNY Progyny PHR Phreesia RAD Rite Aid TDOC Teladoc Health TRHC Tabula Rasa HealthCare WBA Walgreens Boots Alliance XRAY DENTSPLY SIRONA ALGN Align Technology CVS CVS Health GDRX GoodRx Holdings RCM R1 RCM ACCD Accolade AMWL American Well ATHN CHNG Change Healthcare HIMS Hims & Hers Health DH TALK VCRA Vocera Communications TEVA Teva Pharmaceutical Industries VTRS

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Charles Rhyee (COWEN)